Meclizine Hydrochloride Tablet
Product Images NDC 65162-441

NDC 65162-441-03 Meclizine Hydrochloride Tablets, USP CAN LY is a prescription medication used for the treatment of vertigo. This medication is often taken at doses of 25-100mg per day, depending on clinical response, as directed in accompanying prescribing information. Each tablet contains 12.5mg meclizine dihydrochloride equivalent to 10.53mg of meclizine free base, and should be kept in a tightly closed, light-resistant container at temperatures between 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). This medication should be kept away from children, and is distributed by Amneal Pharmaceuticals LLC. Lot and expiration date are available in a non-varnish area.*

Meclizine Hydrochloride Tablets are indicated for the treatment of vertigo. Each tablet contains 25 mg of meclizine dihydrochloride equivalent to 21.07 mg of meclizine free base. The usual dosage is 25 mg to 100 mg in divided doses daily depending on the clinical response. They should be dispensed in tight, light-resistant containers and should be stored at 20° to 25°C (68° to 77°F) with permitted excursions between 15° to 30°C (59° to 86°F). This medication is distributed by Amneal Pharmaceuticals LLC and caution should be taken to keep it out of the reach of children.*

This is a description of a medication containing Meclizine dihydrochloride used to treat vertigo, packaged in tablet form with a dosage range of 25mg to 100mg per day, and should be stored in tight, light-resistant containers at 20°C to 25°C. The medication should be kept away from children and distributed by Amneal Pharmaceuticals LLC.*